Converging Physiological Roles of the Anthrax Toxin Receptors [Version 1; Peer Review: 3 Approved] Oksana A

Total Page:16

File Type:pdf, Size:1020Kb

Load more

F1000Research 2019, 8(F1000 Faculty Rev):1415 Last updated: 12 AUG 2019 REVIEW Converging physiological roles of the anthrax toxin receptors [version 1; peer review: 3 approved] Oksana A. Sergeeva , F. Gisou van der Goot Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland First published: 12 Aug 2019, 8(F1000 Faculty Rev):1415 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.19423.1) Latest published: 12 Aug 2019, 8(F1000 Faculty Rev):1415 ( https://doi.org/10.12688/f1000research.19423.1) Reviewer Status Abstract Invited Reviewers The anthrax toxin receptors—capillary morphogenesis gene 2 (CMG2) and 1 2 3 tumor endothelial marker 8 (TEM8)—were identified almost 20 years ago, although few studies have moved beyond their roles as receptors for the version 1 anthrax toxins to address their physiological functions. In the last few years, published insight into their endogenous roles has come from two rare diseases: 12 Aug 2019 hyaline fibromatosis syndrome, caused by mutations in CMG2, and growth retardation, alopecia, pseudo-anodontia, and optic atrophy (GAPO) syndrome, caused by loss-of-function mutations in TEM8. Although CMG2 F1000 Faculty Reviews are written by members of and TEM8 are highly homologous at the protein level, the difference in the prestigious F1000 Faculty. They are disease symptoms points to variations in the physiological roles of the two commissioned and are peer reviewed before anthrax receptors. Here, we focus on the similarities between these publication to ensure that the final, published version receptors in their ability to regulate extracellular matrix homeostasis, angiogenesis, cell migration, and skin elasticity. In this way, we shed light is comprehensive and accessible. The reviewers on how mutations in these two related proteins cause such seemingly who approved the final version are listed with their different diseases and we highlight the existing knowledge gaps that could names and affiliations. form the focus of future studies. Keywords 1 Michael S Rogers, Harvard Medical School, anthrax toxin receptors, CMG2, TEM8, HFS, ISH, JHF, GAPO Boston, USA 2 James G Bann, Wichita State University, Wichita, USA 3 Brad St. Croix, National Institutes of Health, Frederick, USA Any comments on the article can be found at the end of the article. Page 1 of 10 F1000Research 2019, 8(F1000 Faculty Rev):1415 Last updated: 12 AUG 2019 Corresponding authors: Oksana A. Sergeeva ([email protected]), F. Gisou van der Goot ([email protected]) Author roles: Sergeeva OA: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; van der Goot FG: Conceptualization, Funding Acquisition, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests: No competing interests were disclosed. Grant information: This work was funded by Swiss National Science Foundation grant #310030B_176393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2019 Sergeeva OA and van der Goot FG. This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite this article: Sergeeva OA and van der Goot FG. Converging physiological roles of the anthrax toxin receptors [version 1; peer review: 3 approved] F1000Research 2019, 8(F1000 Faculty Rev):1415 (https://doi.org/10.12688/f1000research.19423.1) First published: 12 Aug 2019, 8(F1000 Faculty Rev):1415 (https://doi.org/10.12688/f1000research.19423.1) Page 2 of 10 F1000Research 2019, 8(F1000 Faculty Rev):1415 Last updated: 12 AUG 2019 Introduction Anthrax toxin receptor structure and epistructure In the early 2000s, two newly discovered proteins—capillary Both CMG2 and TEM8 are type I transmembrane proteins con- morphogenesis gene 2 (CMG2) and tumor endothelial marker sisting of an extracellular von Willebrand factor type A (vWA) 8 (TEM8)—were demonstrated to be anthrax toxin recep- that is also found in integrins and participates in receptor– tors (ANTXRs)1,2. Since then, much research has focused on ligand interactions, an extracellular immunoglobulin-like their toxin-related pathogenic roles (most recently reviewed (Ig-like) domain, and a long cytoplasmic tail that is predicted by Friebe et al.3 and Sun and Jacquez4). However, both to be largely unstructured and contains an actin–cytoskeleton CMG2, encoded by the ANTXR2 gene, and TEM8, encoded interacting domain (Figure 1). The structure of the extracellular by the ANTXR1 gene, also possess physiological roles in ver- domains was analyzed by low-resolution cryo-electron micro- tebrates, the study of which has not received nearly the same scopy, onto which the x-ray structure of the vWA domain8,9 level of attention. What has helped to drive research into their and a model of the Ig-like domain10,11 were successfully endogenous roles is that both receptors are associated with docked. CMG2 and TEM8 have long cytosolic tails of 148 recessive autosomal diseases: mutations in CMG2 lead to hya- and 222 residues, respectively, which are predicted to be intrin- line fibromatosis syndrome (HFS), whereas mutations in sically unstructured like the cytoplasmic domains of many TEM8 result in growth retardation, alopecia, pseudo-anodontia, other signaling receptors12. These tails could allow sequential and optic atrophy (GAPO) syndrome5–7. The literature contains interaction with diverse partner molecules13 and were also reports of some 350 HFS patients of whom 112 have been found to be the site of various post-translational modifications, genotyped, possessing 56 different mutations. In parallel, such as S-palmitoylation14, ubiquitination14, and tyrosine- 70 GAPO patients have been reported, 21 of which have geno- phosphorylation15, all of which were found to be necessary for type information, comprising 14 different mutations. Even toxin-induced endocytosis3. The CMG2 and TEM8 tails are though these diseases have grossly different symptoms, CMG2 completely identical in certain segments but have no homol- and TEM8 share 62% sequence similarity, reasonably allowing ogy in others16, pointing toward similarities and differences, for some overlapping structure/function relationship and respectively, in interacting partners. The most highly conserved ensuring that a better understanding of the function of one portion between the two receptors, which is juxtamembrane, receptor can prompt progress on the other. Therefore, this has homology with the actin-regulating Wiskott–Aldrich syn- review aims to synthesize the latest information on these drome protein17. Relatedly, TEM8 was also consistently shown to ANTXRs with earlier established observations to better under- interact with actin18,19, although this interaction may be indirect stand their physiological functions and provide open pathways and require adaptor proteins, such as those observed for for future research. integrins20. Figure 1. TEM8 and CMG2 are similar in gene and protein structure: mutations in the former lead to GAPO and those in the latter lead to HFS. Tumor endothelial marker 8 (TEM8) (blue) and capillary morphogenesis gene 2 (CMG2) (green) have similar exon schemes and protein structures. Crystal structures of the von Willebrand factor type A (vWA) domain of TEM8 (Protein Data Bank [PDB]: 3N2N8) and CMG2 (PDB: 1TZN9) are shown aligned. The immunoglobulin (Ig)-like and transmembrane domains have been modelled on CMG2 and are shown in gray10. The cytosolic tails, longer for TEM8 than for CMG2, are intrinsically disordered with a conserved juxtamembranous actin- binding domain (ABD). The number of reported occurrences of mutations in growth retardation, alopecia, pseudo-anodontia, and optic atrophy (GAPO) is depicted next to TEM8, and the corresponding number in hyaline fibromatosis syndrome (HFS) is shown next to CMG2. The number of HFS patients with mutations in CMG2 is almost an order of magnitude higher than those of GAPO/TEM8. Page 3 of 10 F1000Research 2019, 8(F1000 Faculty Rev):1415 Last updated: 12 AUG 2019 Receptors for anthrax toxin which was named in 198625, and juvenile hyaline fibromatosis The function of CMG2 and TEM8 as ANTXRs has been (JHF), first described in 1873 by Murray26 and named in 197627. extensively studied. The surface residence time of ANTXRs Initially, these terms were thought to describe two different dis- is regulated by S-palmitoylation at three or four sites in their eases with overlapping symptoms, including subcutaneous cytoplasmic tails, as shown for TEM814, and under “resting” nodules, gingival hypertrophy, painful joint contractures, and conditions, TEM8 is associated with the actin cytoskeleton15,21 persistent infections. ISH is, however, more severe with death (Figure 2A). As opposed to how integrins concurrently inter- occurring before the age of two because of protein-losing enter- act with their ligand and the cytoskeleton, upon binding of a opathy. In the early 2000s, patients with both JHF and ISH ligand such as anthrax toxin protective antigen (PA), the inter- were found to have mutations in CMG25,6,28, pointing to the action of TEM8 with the actin cytoskeleton is released. Upon disease causality. This allowed the classification of a unified ligand binding, PA oligomerizes into a heptameric or octa- syndrome with a symptom grading system, placing the pre- meric complex, leading
Recommended publications
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway

    Analysis of the Indacaterol-Regulated Transcriptome in Human Airway

    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
  • Bioinformatics Analysis Based on Gene Expression Omnibus

    Bioinformatics Analysis Based on Gene Expression Omnibus

    ANTICANCER RESEARCH 39 : 1689-1698 (2019) doi:10.21873/anticanres.13274 Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus JUN-BAO LIU 1* , TUNYU JIAN 2* , CHAO YUE 3, DAN CHEN 4, WEI CHEN 5, TING-TING BAO 6, HAI-XIA LIU 7, YUN CAO 8, WEI-BING LI 6, ZHIJIAN YANG 9, ROBERT M. HOFFMAN 9 and CHEN YU 6 1Traditional Chinese Medicine Department, People's Hospital of Henan Province, People's Hospital of Zhengzhou University, Zhengzhou, P.R. China; 2Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, P.R. China; 3Department of general surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, P.R. China; 4Research Center of Clinical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, P.R. China; 5Department of Head and Neck Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, P.R. China; 6Department of Integrated TCM & Western Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, P.R. China; 7Emergency Department, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, P.R. China; 8Master candidate of Oncology, Nanjing University of Chinese Medicine, Nanjing, P.R. China; 9AntiCancer, Inc., San Diego, CA, U.S.A. Abstract. Background/Aim: This study aimed to identify identified, including 13 up-regulated and 1,473 down-regulated biomarkers for predicting the prognosis of advanced gastric genes.
  • HHS Public Access Author Manuscript

    HHS Public Access Author Manuscript

    HHS Public Access Author manuscript Author Manuscript Author ManuscriptOncogene Author Manuscript. Author manuscript; Author Manuscript available in PMC 2015 July 02. Published in final edited form as: Oncogene. 2015 January 2; 34(1): 94–103. doi:10.1038/onc.2013.523. Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma Paul N. Valdmanis1,2, Biswajoy Roy-Chaudhuri1,2, Hak Kyun Kim1,2, Leanne C. Sayles3, Yanyan Zheng3, Chen-Hua Chuang2,4,5, Deborah R. Caswell2,4,5, Kirk Chu1,2, Monte M. Winslow2,4,5, E. Alejandro Sweet-Cordero1,3,5, and Mark A. Kay1,2 1Department of Pediatrics, Stanford University, Stanford, CA, USA 2Department of Genetics, Stanford University, Stanford, CA, USA 3Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, CA, USA 4Cancer Biology Program, Stanford University, Stanford, CA, USA 5Stanford Cancer Institute, Stanford University, Stanford, CA, USA Abstract Mice in which lung epithelial cells can be induced to express an oncogenic KrasG12D develop lung adenocarcinomas in a manner analogous to humans. A myriad of genetic changes accompany lung adenocarcinomas, many of which are poorly understood. To get a comprehensive understanding of both the transcriptional and post-transcriptional changes that accompany lung adenocarcinomas, we took an omics approach in profiling both the coding genes and the non- coding small RNAs in an induced mouse model of lung adenocarcinoma. RNAseq transcriptome analysis of KrasG12D tumors from F1 hybrid mice revealed features specific to tumor samples. This includes the repression of a network of GTPase related genes (Prkg1, Gnao1 and Rgs9) in tumor samples and an enrichment of Apobec1-mediated cytosine to uridine RNA editing.
  • Targeting the DEK Oncogene in Head and Neck Squamous Cell Carcinoma: Functional and Transcriptional Consequences

    Targeting the DEK Oncogene in Head and Neck Squamous Cell Carcinoma: Functional and Transcriptional Consequences

    Targeting the DEK oncogene in head and neck squamous cell carcinoma: functional and transcriptional consequences A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements to the degree of Doctor of Philosophy (Ph.D.) in the Department of Cancer and Cell Biology of the College of Medicine March 2015 by Allie Kate Adams B.S. The Ohio State University, 2009 Dissertation Committee: Susanne I. Wells, Ph.D. (Chair) Keith A. Casper, M.D. Peter J. Stambrook, Ph.D. Ronald R. Waclaw, Ph.D. Susan E. Waltz, Ph.D. Kathryn A. Wikenheiser-Brokamp, M.D., Ph.D. Abstract Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignancies worldwide with over 50,000 new cases in the United States each year. For many years tobacco and alcohol use were the main etiological factors; however, it is now widely accepted that human papillomavirus (HPV) infection accounts for at least one-quarter of all HNSCCs. HPV+ and HPV- HNSCCs are studied as separate diseases as their prognosis, treatment, and molecular signatures are distinct. Five-year survival rates of HNSCC hover around 40-50%, and novel therapeutic targets and biomarkers are necessary to improve patient outcomes. Here, we investigate the DEK oncogene and its function in regulating HNSCC development and signaling. DEK is overexpressed in many cancer types, with roles in molecular processes such as transcription, DNA repair, and replication, as well as phenotypes such as apoptosis, senescence, and proliferation. DEK had never been previously studied in this tumor type; therefore, our studies began with clinical specimens to examine DEK expression patterns in primary HNSCC tissue.
  • Alterations of the Pro-Survival Bcl-2 Protein Interactome in Breast Cancer

    Alterations of the Pro-Survival Bcl-2 Protein Interactome in Breast Cancer

    bioRxiv preprint doi: https://doi.org/10.1101/695379; this version posted July 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Alterations of the pro-survival Bcl-2 protein interactome in 2 breast cancer at the transcriptional, mutational and 3 structural level 4 5 Simon Mathis Kønig1, Vendela Rissler1, Thilde Terkelsen1, Matteo Lambrughi1, Elena 6 Papaleo1,2 * 7 1Computational Biology Laboratory, Danish Cancer Society Research Center, 8 Strandboulevarden 49, 2100, Copenhagen 9 10 2Translational Disease Systems Biology, Faculty of Health and Medical Sciences, Novo 11 Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, 12 Denmark 13 14 Abstract 15 16 Apoptosis is an essential defensive mechanism against tumorigenesis. Proteins of the B-cell 17 lymphoma-2 (Bcl-2) family regulates programmed cell death by the mitochondrial apoptosis 18 pathway. In response to intracellular stresses, the apoptotic balance is governed by interactions 19 of three distinct subgroups of proteins; the activator/sensitizer BH3 (Bcl-2 homology 3)-only 20 proteins, the pro-survival, and the pro-apoptotic executioner proteins. Changes in expression 21 levels, stability, and functional impairment of pro-survival proteins can lead to an imbalance 22 in tissue homeostasis. Their overexpression or hyperactivation can result in oncogenic effects. 23 Pro-survival Bcl-2 family members carry out their function by binding the BH3 short linear 24 motif of pro-apoptotic proteins in a modular way, creating a complex network of protein- 25 protein interactions.
  • Key Genes Associated with Pancreatic Cancer and Their Association with Outcomes: a Bioinformatics Analysis

    Key Genes Associated with Pancreatic Cancer and Their Association with Outcomes: a Bioinformatics Analysis

    MOLECULAR MEDICINE REPORTS 20: 1343-1352, 2019 Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis JIAJIA WU1*, ZEDONG LI2*, KAI ZENG1, KANGJIAN WU1, DONG XU3, JUN ZHOU2 and LIJIAN XU1 1Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000; 2Department of Minimally Invasive Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011; 3Department of General Surgery, Gaochun People's Hospital, Nanjing, Jiangsu 211300, P.R. China Received October 4, 2018; Accepted April 9, 2019 DOI: 10.3892/mmr.2019.10321 Abstract. Pancreatic cancer is a highly malignant neoplastic that the expression of COL17A1 gene may be associated with disease of the digestive system. In the present study, the the occurrence and development of pancreatic cancer. dataset GSE62165 was downloaded from the Gene Expression Omnibus (GEO) database. GSE62165 contained the data of Introduction 118 pancreatic ductal adenocarcinoma samples (38 early-stage tumors, 62 lymph node metastases and 18 advanced tumors) Pancreatic cancer is a highly malignant neoplasm of the diges- and 13 control samples. Differences in the expression levels tive system that accounts for >200,000 deaths/year globally (1). of genes between normal tissues and early-stage tumors were The incidence of pancreatic cancer is low compared with that investigated. A total of 240 differentially expressed genes of lung, breast, colorectal and gastric cancers; however, it is (DEGs) were identified using R software 3.5 (137 upregulated associated with a very high mortality rate. It has been reported genes and 103 downregulated genes). Then, the differentially that the incidence of pancreatic cancer is very similar to the expressed genes were subjected to Gene Ontology and Kyoto associated mortality rate; the reported 5-year survival rate of Encyclopedia of Genes and Genomes analysis.
  • Identification of Candidate Genes Related to Pancreatic Cancer Based on Analysis of Gene Co-Expression and Protein-Protein Interaction Network

    Identification of Candidate Genes Related to Pancreatic Cancer Based on Analysis of Gene Co-Expression and Protein-Protein Interaction Network

    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 41), pp: 71105-71116 Research Paper Identification of candidate genes related to pancreatic cancer based on analysis of gene co-expression and protein-protein interaction network Tiejun Zhang1, Xiaojuan Wang2 and Zhenyu Yue2 1GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China 2Institute of Health Sciences, School of Computer Science and Technology, Anhui University, Hefei, Anhui 230601, China Correspondence to: Zhenyu Yue, email: [email protected] Keywords: pancreatic cancer, candidate genes, gene co-expression, protein-protein interaction network, subnetwork extraction algorithm Received: May 14, 2017 Accepted: July 29, 2017 Published: August 24, 2017 Copyright: Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Pancreatic cancer (PC) is one of the most common causes of cancer mortality worldwide. As the genetic mechanism of this complex disease is not uncovered clearly, identification of related genes of PC is of great significance that could provide new insights into gene function as well as potential therapy targets. In this study, we performed an integrated network method to discover PC candidate genes based on known PC related genes. Utilizing the subnetwork extraction algorithm with gene co- expression profiles and protein-protein interaction data, we obtained the integrated network comprising of the known PC related genes (denoted as seed genes) and the putative genes (denoted as linker genes).
  • Bioinformatics Analysis: the Regulatory Network of Hsa Circ 0007843 and Hsa Circ 0007331 in Colon Cancer

    Bioinformatics Analysis: the Regulatory Network of Hsa Circ 0007843 and Hsa Circ 0007331 in Colon Cancer

    Hindawi BioMed Research International Volume 2021, Article ID 6662897, 9 pages https://doi.org/10.1155/2021/6662897 Research Article Bioinformatics Analysis: The Regulatory Network of hsa_circ_ 0007843 and hsa_circ_0007331 in Colon Cancer Zeping Han ,1 Huafang Chen ,2 Zhonghui Guo,1 Jianxia Zhu,1 Xingyi Xie,1 Yuguang Li ,1 and Jinhua He 1 1Department of Laboratory Medicine, Central Hospital of Panyu District, Guangzhou, Guangdong 511400, China 2Leizhou Center for Disease Control and Prevention, Leizhou, Guangdong 524200, China Correspondence should be addressed to Yuguang Li; [email protected] and Jinhua He; [email protected] Received 5 October 2020; Revised 8 June 2021; Accepted 5 July 2021; Published 23 July 2021 Academic Editor: Federico Zambelli Copyright © 2021 Zeping Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. To analyze the molecular regulation network of circular RNA (circRNA) in colon cancer (CC) by bioinformatics method. Methods. hsa_circ_0007843 and hsa_circ_0007331 proved to be associated with CC in previous studies were chosen as the research object. ConSite database was used to predict the transcription factors associated with circRNA, and the CC-associated transcription factors were screened out after intersection. The CircInteractome database was used to predict the RNA-binding proteins (RBPs) interacting with circRNAs and screen out the CC-associated RBPs after an intersection. Furthermore, the CircInteractome database was used to predict the miRNAs interrelated with circRNAs, and the HMDD v3.2 database was used to search for miRNAs associated with CC.
  • Patel, a Et Al. 1 Integrative Genomic and Epigenomic Analyses Identify A

    Patel, a Et Al. 1 Integrative Genomic and Epigenomic Analyses Identify A

    bioRxiv preprint doi: https://doi.org/10.1101/852939; this version posted November 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Patel, A et al. 1 Integrative genomic and epigenomic analyses identify a distinct role of c-Myc and L-Myc for lineage determination in small cell lung cancer Ayushi S. Patel1,2, Seungyeul Yoo3,4, Ranran Kong1,2,5, Takashi Sato1,2, Maya Fridrikh1,2, Abhilasha Sinha1,2, German Nudelman6, Charles A. Powell1,2, Mary Beth Beasley7, Jun Zhu2,3,4, Hideo Watanabe1,2,3,8* 1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 3Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 4Sema4, a Mount Sinai venture, Stamford, CT 06902, USA. 5Department of Thoracic Surgery, The Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China 6 Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 7Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 8Lead Contact *Correspondence: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/852939; this version posted November 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
  • Annofuse: an R Package to Annotate, Prioritize, and Interactively Explore Putative

    Annofuse: an R Package to Annotate, Prioritize, and Interactively Explore Putative

    bioRxiv preprint doi: https://doi.org/10.1101/839738; this version posted September 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions Krutika S. Gaonkar1,2,3,+, Federico Marini4,5,+, Komal S. Rathi1,2,3, Payal Jain1,3, Yuankun Zhu1,3, Nicholas A. Chimicles1,2, Miguel A. Brown1,3, Ammar S. Naqvi1,2,3, Bo Zhang1,3, Phillip B. Storm1,3, John M. Maris6, Pichai Raman1,2,3, Adam C. Resnick1,2,3, Konstantin Strauch4, Jaclyn N. Taroni7,*, Jo Lynne Rokita1,2,3* 1Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia, Philadelphia, PA, USA 2Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA 3Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA 4Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany 5Center for Thrombosis and Hemostasis, Mainz, Germany 6Division of Oncology, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA 7Alex’s Lemonade Stand Foundation Childhood Cancer Data Lab, Philadelphia, PA, USA +Authors contributed equally *Corresponding Authors: Jo Lynne Rokita, Ph.D. ([email protected]) and Jaclyn N. Taroni, Ph.D. ([email protected]) bioRxiv preprint doi: https://doi.org/10.1101/839738; this version posted September 19, 2020.
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards

    Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards

    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
  • Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression

    Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression

    Communication Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression Zhang Zhang, Yan Zhang, Minglei Shi, Bingyu Ye, Wenlong Shen, Ping Li, Lingyue Xing, Xiaopeng Zhang, Lihua Hou, Junjie Xu *, Zhihu Zhao * and Wei Chen * Received: 11 September 2015; Accepted: 9 December 2015; Published: 22 December 2015 Academic Editor: Shihui Liu Beijing Institute of Biotechnology, No. 20, Dongdajie str., Fengtai District, Beijing 100071, China; [email protected] (Z.Z.); [email protected] (Y.Z.); [email protected] (M.S.); [email protected] (B.Y.); [email protected] (W.S.); [email protected] (P.L.); [email protected] (L.X.); [email protected] (X.Z.); [email protected] (L.H.) * Correspondence: [email protected] (J.X.); [email protected] (Z.Z.); [email protected] (W.C.); Tel.: +86-10-6694-8565 (J.X.); +86-10-6694-8763 (Z.Z.); +86-10-6694-8801 (W.C.); Fax: +86-10-6381-8253 (J.X. & Z.Z.); +86-10-6381-5273 (W.C.) Abstract: Anthrax toxin causes anthrax pathogenesis and expression levels of ANTXR2 (anthrax toxin receptor 2) are strongly correlated with anthrax toxin susceptibility. Previous studies found that ANTXR2 transcript abundance varies considerably in individuals of different ethnic/geographical groups, but no eQTLs (expression quantitative trait loci) have been identified. By using 3C (chromatin conformation capture), CRISPR-mediated genomic deletion and dual-luciferase reporter assay, gene loci containing cis-regulatory elements of ANTXR2 were localized. Two SNPs (single nucleotide polymorphism) at the conserved CREB-binding motif, rs13140055 and rs80314910 in the promoter region of the gene, modulating ANTXR2 promoter activity were identified.